Dr. Dube is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1300 N Mission Rd
Room 349
Los Angeles, CA 90033Phone+1 323-343-8288- Is this information wrong?
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Infectious Disease, 1990 - 1992
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1983 - 1986
- Boston University School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1985 - 2025
- IN State Medical License 2000 - 2009
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients Start of enrollment: 1999 Apr 01
- Effects of Storage on Lactate in Blood Samples Start of enrollment: 2001 Jan 01
- Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsA Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.Rachel M Presti, Eunice Yeh, Brett Williams, Alan Landay, Jeffrey M Jacobson, Cara Wilson, Carl J Fichtenbaum, Netanya S Utay, Michael P Dube, Karin L Klingman, Jacob ...> ;Open Forum Infectious Diseases. 2021 Dec 1
- 5 citationsAdipokines, Weight Gain and Metabolic and Inflammatory Markers after Antiretroviral Therapy Initiation: ACTG A5260sJohn R. Koethe, Carlee Moser, Todd T. Brown, James H. Stein, Theodoros Kelesidis, Michael P. Dubé, Judith S. Currier, Grace A. McComsey> ;Clinical Infectious Diseases. 2021 Jun 12
- 3 citationsCharacteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners.Adiba Hassan, Joel O. Wertheim, Jill Blumenthal, Eric Ellorin, Michael P. Dubé, Katya Corado, David J. Moore, Sheldon R. Morris> ;Medicine. 2019 Dec 1
- Join now to see all
Journal Articles
- Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex with MenJill Blumenthal, David J Moore, Michael P Dube, Sheldon R Morris, The Journal of Infectious Diseases
Press Mentions
- Keck Medicine of USC Enrolling Volunteers to Test COVID-19 DrugNovember 19th, 2020
- USC Seeking Vernon Factory Workers to Volunteer for COVID-19 Vaccine TrialAugust 17th, 2020
- Keck Medicine to Launch Clinical Trial for Coronavirus TreatmentMay 7th, 2020
Grant Support
- Switch To Atazanavir And Brachial Artery Reactivity (SABAR) Study: EndotheliaNational Center For Research Resources2007–2008
- Cross-Sectional And Longitudinal Study Of Endothelial Function By Brachial Flow-National Center For Research Resources2007–2008
- A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)National Center For Research Resources2007–2008
- A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of UridineNational Center For Research Resources2007–2008
- Pilot Study To Establish The Use Of Brachial Ultrasound To Measure Vascular RNational Center For Research Resources2006–2008
- PLAN For Obtaining Informed Consent To Use Stored Human Biological MaterialsNational Center For Research Resources2004–2008
- Effect Of HIV-1 Protease Inhibitors On Endothelial Function And GlucoseNational Center For Research Resources2004–2008
- A Phase IIIB, Open-Label, Randomized, Multi-Center Study Comparing The AntiviNational Center For Research Resources2006
- Immuno &Viro Indices To Study The HIV Disease Progression Assoc W/AgingNational Center For Research Resources2005–2006
- A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, ParaNational Center For Research Resources2005–2006
- A Phase II Trial Of The Effect Of Combination Therapy With Fish Oil SupplemenNational Center For Research Resources2005–2006
- Trial Of Physiologic Testosterone Supplementation For Hiv-Positive(A5079)National Center For Research Resources2004–2006
- Effect Of A Protease Inhibitor-Containing Or A Non-Protease Inhibitor-ContainingNational Center For Research Resources2004–2006
- Study Of Metformin &Rosiglitazone Alone/In Combo In Hiv-Infected PTSNational Center For Research Resources2005
- Thymidine Analogue Substitution Or Change To A Nucleoside-Sparing RegimenNational Center For Research Resources2004–2005
- Extended-Release Niacin For The Treatment Of Elevated Non-Hdl CholesterolNational Center For Research Resources2004–2005
- Alendronate In Hiv-Infected Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2004–2005
- Endothelial Dysfunction Due To HIV-1 Protease InhibitorsNational Heart, Lung, And Blood Institute2002–2005
- Temporary Cessation Of ART &Resistance Testing In Response To Salvage TherapyNational Center For Research Resources2004
- Study Of Metformin &Rosiglitazone Alone/In Combo In Hiv-Infected PTS.National Center For Research Resources2004
- Immuno &Viro Indices To Study The HIV Disease Progression Assoc. W/AgingNational Center For Research Resources2004
Hospital Affiliations
- Keck Hospital of USCLos Angeles, California
- Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: